Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Design, rationale, and baseline characteristics of the randomized double-blind phase II clinical trial of ibudilast in progressive multiple sclerosis.
Educational achievements of children of parents with multiple sclerosis: A nationwide register-based cohort study.
A new dawn for genetic association studies in multiple sclerosis.
Clinical characteristics of disabling attacks at onset in patients with neuromyelitis optica spectrum disorder.
The Perceived Deficits Questionnaire: Perception, Deficit, or Distress?
Probiotics Lactobacillus plantarum and bifidobacterium B94: cognitive function in demyelinated model.
Multiple Autoantibodies and Neuromyelitis Optica Spectrum Disorders.
Cardiac Safety Profile of First Dose of Fingolimod for Relapsing-Remitting Multiple Sclerosis in Real-World Settings: Data from a German Prospective Multi-Center Observational Study.
Therapeutic benefit of botulinum toxin A for the spasticity of the triceps surae in patients with multiple sclerosis: An observational study.
Zika virus infection and Guillain-Barré syndrome: a review focused on clinical and electrophysiological subtypes.
Lithium to the Rescue.
Tadalafil Promotes the Recovery of Peripheral Neuropathy in Type II Diabetic Mice.
Comparison between gadolinium-enhanced 2D T1-weighted gradient-echo and spin-echo sequences in the detection of active multiple sclerosis lesions on 3.0T MRI.
Quality of life in relapsing-remitting multiple sclerosis patients receiving CinnoVex compared with Avonex.
Cuprizone demyelination induces a unique inflammatory response in the subventricular zone.
Pediatric multiple sclerosis: Cognition and mood.
Dynamic Response Genes in CD4+ T Cells Reveal a Network of Interactive Proteins that Classifies Disease Activity in Multiple Sclerosis.
Depressive Symptoms Correlate with Disability and Disease Course in Multiple Sclerosis Patients: An Italian Multi-Center Study Using the Beck Depression Inventory.
Axonal pathology in Krabbe's disease: The cytoskeleton as an emerging therapeutic target.
Rebound Syndrome in Multiple Sclerosis After Fingolimod Cessation.
Multiple Sclerosis and Obesity: Possible Roles of Adipokines.
Anti-CD20 monoclonal antibodies in multiple sclerosis.
Dimethyl fumarate alters microglia phenotype and protects neurons against proinflammatory toxic microenvironments.
Pharmaceutical Approval Update.
Webwise.
Pages
« first
‹ previous
…
819
820
821
822
823
824
825
826
827
…
next ›
last »